Phoenix, Arizona--(Newsfile Corp. - November 25, 2019) - The Stock Day Podcast welcomed CanaQuest Medical Corp. (OTC Pink: CANQF) ("the Company"), a company engaged in the development of unique health products and nutraceuticals that utilize hemp, cannabis and algae oils. Chairman and Co-Founder of the Company, Paul Ramsay, joined Stock Day host Everett Jolly.
Jolly began the interview by asking about the Company's current projects. Ramsay shared that the Company recently announced the filing of an international master patent. "For this one, we're looking at a game changing discovery with Mentabinol®," said Ramsay. He further explained that Mentabinol® protects cannabis users from the negative psychoactive effects of THC. "This is going to be very impactful for the industry," added Ramsay. "In essence, what we're offering is a safer alternative for users of cannabis," said Ramsay. He then explained that Mentabinol® could be used by both medical and recreational users of cannabis.
"What kind of problems are you solving with this formulation?", asked Jolly. "We've narrowed it down to four major problems as a result of THC consumption," explained Ramsay. These problems include depression-like symptoms, memory impairments, hyperactive activity, and gene vulnerability.
Jolly noted that the Company is currently pre-revenue, and asked about their monetization strategy for Mentabinol®. Ramsay shared that Mentabinol® will be listed similarly to existing medical cannabis extracts available on the market. "We've combined THC extract with a food-grade botanical extract that in its own right is already approved by the FDA, Health Canada, and global regulatory authorities," said Ramsay.
Ramsay then shared that the Company plans to begin distributing the product in Canada as soon as January. Following the launch of the formulation, the Company will begin the process of exporting on a global scale.
Jolly then asked about the Company's additional products. Ramsay explained that the Company has an additional CBD product that will be launching within one to two months.
To close the interview, Ramsay shared that the Company has been awarded a cannabis sales license, as well as an import and export license from Health Canada. "That's very powerful," said Ramsay. "We can expand globally very easily by choosing the right partners," he added. He further explained that the Company is continuing to expand their eCommerce presence, and is establishing their distribution channels to prepare for a global launch. "We're aligned and we're all very passionate about making an impact on peoples' lives," closed Ramsay.
To hear Paul Ramsay's entire interview, follow the link to the podcast here: https://audioboom.com/posts/7433563-canaquest-medical-corp-joins-stock-day-podcast-to-discuss-global-expansion-plans
About CanaQuest Medical Corp.
CanaQuest Medical Corp is engaged in the development of unique health products and nutraceuticals that utilize hemp, cannabis and algae oils. The Company has engaged two Canadian universities to provide research into the use of botanical extracts and cannabis formulations, which the company plans to use to develop products that combine the significant health benefits of botanical extracts and extracts from cannabis oil. Our research is focused on the use of cannabis in the context of cancer and the use of cannabis derivatives for the development of our novel pharmacotherapies for mental health, such as anxiety, depression, addiction, schizophrenia, and Post Traumatic Stress Disorder "PTSD". CanaQuest, through its wholly owned subsidiary, ADC Biomedical Corp., has obtained a purchase/sale, import/export license for cannabis and cannabis products (non-possession) as permitted under the Health Canada Cannabis Act.
For more information, visit our website at http://www.canaquest.com.
This news release contains "forward-looking statements" as that term is defined in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, use of proceeds and the development, costs and results of current or future actions and opportunities in the sector. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies, our ability to raise the additional funding we will need to continue to pursue our exploration and development program, and our ability to retain important members of our management team and attract other qualified personnel. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate.
Investors should consult all the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
Paul Ramsay, Co-Founder & President, CanaQuest Medical Corp
About The "Stock Day" Podcast
Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America. Stock Day recently launched its Video Interview Studio located in Phoenix, Arizona.
Stock Day Media
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/50053